The National Nuclear Security Agency, a semiautonomous department of the DOE announced it is awarding North Star Medical Technologies with $37 million in cost-shared funding under two-cooperative agreements. This funding will allow North Star to finish the first phase of its $80 million facility in Beloit, Wis., and expand production at its research reactor in Missouri.
The NNSA also provided cost-shared funding to SHINE Medical Technologies, of Janesville, Wis.; Niowave, of Lansing, Mich.; and Northwest Medical Isotopes, based in Corvallis, Ore. All four of these companies are pursuing the production of Mo-99 using a different non-HEU technology.
Link: NorthStar awarded $37 million for Mo-99 production — ANS / Nuclear Newswire